The injected medication, liraglutide, is under review by the FDA to treat type 2 diabetes. In a study, three-quarters of patients on high doses of the drug lost 5% or more of their body weight. A medication that is under review by the Food and Drug Administration for the treatment of type 2 diabetes may also promote weight loss, according to a study published online Thursday in the Lancet.